Phaarmasia Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 306122, "name": "Phaarmasia", "stock_name": "Phaarmasia", "full_name": "Phaarmasia Ltd", "name_url": "stocks-analysis/phaarmasia", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "81.86", "chg": "0.00", "chgp": "0.00%", "dir": 0, "prev_price": "81.86", "mcapval": "56.00 Cr", "mcap": "Micro Cap", "scripcode": 523620, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE486I01016", "curr_date": "Mar 04", "curr_time": "", "bse_nse_vol": "7 ", "exc_status": "Active", "traded_date": "Mar 04, 2026", "traded_date_str": "2026 03 04", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/phaarmasia-306122-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Phaarmasia Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/phaarmasia-ltd-is-rated-hold-by-marketsmojo-3873051", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PhaarmasiaLtd_mojoScore_3873051.png", "date": "2026-03-05 10:10:53", "description": "Phaarmasia Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 05 March 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing." }, { "title": "Phaarmasia Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/phaarmasia-ltd-is-rated-hold-by-marketsmojo-3849255", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/PhaarmasiaLtd_mojoScore_3849255.png", "date": "2026-02-21 10:10:31", "description": "Phaarmasia Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 21 February 2026, providing investors with an up-to-date view of the company’s performance and outlook." }, { "title": "Phaarmasia Ltd Gains 11.55%: Key Valuation and Technical Upgrades Drive Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/phaarmasia-ltd-gains-1155-key-valuation-and-technical-upgrades-drive-rally-3840701", "imagepath": "", "date": "2026-02-15 09:00:58", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>09 Feb:</strong> Stock opens at ₹108.81 following upgrade to Hold</p>\n <p><strong>10 Feb:</strong> Valuation shifts signal renewed price attractiveness</p>\n <p><strong>12 Feb:</strong> Minor correction amid broader market weakness</p>\n <p><strong>13 Feb:</strong> Week closes at ₹115.60, up 11.55% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹103.63</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">₹115.60</div><div cl..." }, { "title": "Phaarmasia Ltd Upgraded to Hold as Valuation and Technicals Improve", "link": "https://www.marketsmojo.com/news/stock-recommendation/phaarmasia-ltd-upgraded-to-hold-as-valuation-and-technicals-improve-3829845", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/PhaarmasiaLtd_mojoScore_3829845.png", "date": "2026-02-10 08:05:07", "description": "Phaarmasia Ltd has seen its investment rating upgraded from Sell to Hold, reflecting significant improvements across technical indicators and valuation metrics. The company’s recent financial performance, coupled with a bullish technical outlook and attractive valuation compared to peers, has prompted this reassessment by analysts as of 09 Feb 2026." }, { "title": "Phaarmasia Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/phaarmasia-ltd-valuation-shifts-signal-renewed-price-attractiveness-3829521", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/PhaarmasiaLtd_valuationdot_3829521.png", "date": "2026-02-10 08:00:42", "description": "Phaarmasia Ltd has witnessed a significant re-rating in its valuation parameters, transitioning from a previously expensive profile to one now deemed attractive by market standards. This shift is underscored by a notable improvement in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to both historical levels and peer benchmarks within the Pharmaceuticals & Biotechnology sector." }, { "title": "Phaarmasia Ltd Gains 4.68%: Downgrade and Q2 Results Shape the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/phaarmasia-ltd-gains-468-downgrade-and-q2-results-shape-the-week-3827094", "imagepath": "", "date": "2026-02-08 10:00:13", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Feb:</strong> Stock opens at Rs.99.00, Sensex down 1.03%</p>\n <p><strong>4 Feb:</strong> Stock drops 5.00% to Rs.94.05 following downgrade</p>\n <p><strong>5 Feb:</strong> MarketsMOJO downgrades Phaarmasia Ltd to Sell</p>\n <p><strong>6 Feb:</strong> Q2 FY26 results reveal sharp profit growth; stock rebounds to Rs.103.63</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.99.00</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.103...." }, { "title": "Are Phaarmasia Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-phaarmasia-ltd-latest-results-good-or-bad-3826807", "imagepath": "", "date": "2026-02-07 19:17:51", "description": "Phaarmasia Ltd's latest financial results present a mixed picture, highlighting both significant operational improvements in the most recent quarter and underlying structural challenges. In Q2 FY26, the company reported a net profit of ₹1.74 crores, a substantial increase compared to the previous quarter, alongside a remarkable revenue growth of 179.09% year-on-year, reaching ₹16.55 crores. This quarter also marked an operating margin of 9.73%, a notable recovery from a loss in the same quarter of the previous year.\n\nHowever, these positive results must be contextualized against the company's overall performance. For the fiscal year ending March 2025, Phaarmasia experienced a decline in net sales to ₹24.00 crores, down 20% from the previous year, and reported an operating loss of ₹2.00 crores. The recent quarterly spike in performance appears to be an anomaly rather than a sustained trend, as the company ha..." }, { "title": "Phaarmasia Ltd Q2 FY26: Sharp Turnaround Masks Deeper Structural Concerns", "link": "https://www.marketsmojo.com/news/result-analysis/phaarmasia-ltd-q2-fy26-sharp-turnaround-masks-deeper-structural-concerns-3825054", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/Phaarmasia_quaterlyResult_3825054.png", "date": "2026-02-06 21:01:39", "description": "Phaarmasia Limited, a micro-cap pharmaceutical manufacturer specialising in oral contraceptive tablets, delivered a dramatic quarterly turnaround in Q2 FY26, posting net profit of ₹1.74 crores compared to a loss of ₹0.64 crores in the same quarter last year. The 140.90% sequential revenue surge to ₹16.55 crores and return to profitability triggered a 4.99% stock rally to ₹103.63, though the shares remain 21.34% below their 52-week high of ₹131.75." }, { "title": "Are Phaarmasia Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-phaarmasia-ltd-latest-results-good-or-bad-3824771", "imagepath": "", "date": "2026-02-06 19:20:20", "description": "Phaarmasia Ltd's latest financial results for Q2 FY26 reflect a significant turnaround in performance compared to previous periods. The company reported net sales of ₹16.55 crores, which marks a remarkable sequential growth of 140.90% from ₹6.87 crores in Q1 FY26 and a year-on-year increase of 179.09% from ₹5.93 crores in Q2 FY25. This surge in revenue is the highest quarterly figure recorded in at least two years, indicating a potential recovery in operational performance.\n\nNet profit for the quarter reached ₹1.74 crores, a stark contrast to the loss of ₹0.64 crores reported in the same quarter last year. This change represents a substantial improvement in profitability, with the profit after tax (PAT) margin increasing to 10.51% from a negative 10.79% year-on-year. Additionally, the operating margin, excluding other income, expanded to 9.73% from 1.16% in the previous quarter, showcasing enhanced operatio..." } ], "total": 716, "sid": "306122", "stock_news_url": "https://www.marketsmojo.com/news/phaarmasia-306122" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "09-Feb-2026", "details": "Newspaper Advertisement of unaudited Financial results for the Quarter ended 31st December 2025", "source": "BSE" }, { "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 06Th February 2026 At 05.00 PM", "datetime": "06-Feb-2026", "details": "Submission of Outcome of Board Meeting held on Friday 06th February 2026 at 05.00 PM for the Quarter ended 31 December 2025", "source": "BSE" }, { "caption": "Results-Financial Results For The Quarter Ended 31St December 2025", "datetime": "06-Feb-2026", "details": "Submission of Financial results for the Quarter ended 31st December 2025", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

09 Feb: Stock opens at ₹108.81 following upgrade to Hold

10 Feb: Valuation shifts signal renewed price attractiveness

12 Feb: Minor correction amid broader market weakness

13 Feb: Week closes at ₹115.60, up 11.55% for the week

Read full news article

Phaarmasia Ltd Upgraded to Hold as Valuation and Technicals Improve

2026-02-10 08:05:07

Phaarmasia Ltd has seen its investment rating upgraded from Sell to Hold, reflecting significant improvements across technical indicators and valuation metrics. The company’s recent financial performance, coupled with a bullish technical outlook and attractive valuation compared to peers, has prompted this reassessment by analysts as of 09 Feb 2026.

Read full news article

Phaarmasia Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-02-10 08:00:42

Phaarmasia Ltd has witnessed a significant re-rating in its valuation parameters, transitioning from a previously expensive profile to one now deemed attractive by market standards. This shift is underscored by a notable improvement in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to both historical levels and peer benchmarks within the Pharmaceuticals & Biotechnology sector.

Read full news article

Phaarmasia Ltd Gains 4.68%: Downgrade and Q2 Results Shape the Week

2026-02-08 10:00:13

Key Events This Week

2 Feb: Stock opens at Rs.99.00, Sensex down 1.03%

4 Feb: Stock drops 5.00% to Rs.94.05 following downgrade

5 Feb: MarketsMOJO downgrades Phaarmasia Ltd to Sell

6 Feb: Q2 FY26 results reveal sharp profit growth; stock rebounds to Rs.103.63

Read full news article

Are Phaarmasia Ltd latest results good or bad?

2026-02-07 19:17:51

Phaarmasia Ltd's latest financial results present a mixed picture, highlighting both significant operational improvements in the most recent quarter and underlying structural challenges. In Q2 FY26, the company reported a net profit of ₹1.74 crores, a substantial increase compared to the previous quarter, alongside a remarkable revenue growth of 179.09% year-on-year, reaching ₹16.55 crores. This quarter also marked an operating margin of 9.73%, a notable recovery from a loss in the same quarter of the previous year. However, these positive results must be contextualized against the company's overall performance. For the fiscal year ending March 2025, Phaarmasia experienced a decline in net sales to ₹24.00 crores, down 20% from the previous year, and reported an operating loss of ₹2.00 crores. The recent quarterly spike in performance appears to be an anomaly rather than a sustained trend, as the company ha...

Read full news article

Phaarmasia Ltd Q2 FY26: Sharp Turnaround Masks Deeper Structural Concerns

2026-02-06 21:01:39

Phaarmasia Limited, a micro-cap pharmaceutical manufacturer specialising in oral contraceptive tablets, delivered a dramatic quarterly turnaround in Q2 FY26, posting net profit of ₹1.74 crores compared to a loss of ₹0.64 crores in the same quarter last year. The 140.90% sequential revenue surge to ₹16.55 crores and return to profitability triggered a 4.99% stock rally to ₹103.63, though the shares remain 21.34% below their 52-week high of ₹131.75.

Read full news article

Are Phaarmasia Ltd latest results good or bad?

2026-02-06 19:20:20

Phaarmasia Ltd's latest financial results for Q2 FY26 reflect a significant turnaround in performance compared to previous periods. The company reported net sales of ₹16.55 crores, which marks a remarkable sequential growth of 140.90% from ₹6.87 crores in Q1 FY26 and a year-on-year increase of 179.09% from ₹5.93 crores in Q2 FY25. This surge in revenue is the highest quarterly figure recorded in at least two years, indicating a potential recovery in operational performance. Net profit for the quarter reached ₹1.74 crores, a stark contrast to the loss of ₹0.64 crores reported in the same quarter last year. This change represents a substantial improvement in profitability, with the profit after tax (PAT) margin increasing to 10.51% from a negative 10.79% year-on-year. Additionally, the operating margin, excluding other income, expanded to 9.73% from 1.16% in the previous quarter, showcasing enhanced operatio...

Read full news article

View All News